Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

The clinical impact of screening and other experimental tumor studies.

Johnson RK, Goldin A.

Cancer Treat Rev. 1975 Mar;2(1):1-31. Review. No abstract available.

PMID:
1102083
2.

[Potentiation of the antitumor action of alkylating compounds by amphotericin B].

Iaremenko KV, Eremeeva AA, Tereshin IM.

Antibiotiki. 1977;22(2):153-8. Russian. No abstract available.

PMID:
404957
3.

Screening data from the Cancer Chemotherapy National Service Center screening laboratories. XL. Plant extracts.

Abbott BJ, Hartwell JL, Leiter J, Perdue RE Jr, Schepartz SA.

Cancer Res. 1967 Mar;27(3 Pt 2):190-345. No abstract available.

4.

Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XLI. Plant extracts.

Abbott BJ, Hartwell JL, Leiter J, Spetzman LA, Schepartz SA.

Cancer Res. 1967 May;27(5 Pt 2):364-527. No abstract available.

5.

A modified screening system to select new cytostatic drugs.

Kraemer HP, Sedlacek HH.

Behring Inst Mitt. 1984 May;(74):301-28. Review. No abstract available.

PMID:
6383326
6.

Screening data from the Cancer Chemotherapy National Service Center screening laboratories. XXXIX. Plant extracts.

Abbott BJ, Hartwell JL, Leiter J, Perdue RE Jr, Price JR, Schepartz SA.

Cancer Res. 1967 Feb;27(2 Pt 2):1-171. No abstract available.

7.

Combination therapy: some concepts and results.

Skipper HE.

Cancer Chemother Rep 2. 1974 Mar;4(1):137-45. No abstract available.

PMID:
4363649
8.

Attempted drug-tumor sensitivity matching using diffusion chamber-cultivated cells.

Mason BH, Cain BF.

Cancer Treat Rep. 1978 Dec;62(12):2035-43. No abstract available.

PMID:
751713
9.

Some thoughts on experimental models and their clinical correlations.

Carter SK.

Eur J Cancer. 1973 Nov-Dec;9(11-12):833-41. No abstract available.

PMID:
4804310
10.

Alpha-(N)-formylheteroaromatic thiosemicarbazones. Inhibition of tumor-derived ribonucleoside diphosphate reductase and correlation with in vivo antitumor activity.

French FA, Blanz EJ Jr, Shaddix SC, Brockman RW.

J Med Chem. 1974 Feb;17(2):172-81. No abstract available.

PMID:
4809253
11.

Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XXI.

Leiter J, Abbott BJ, Schepartz SA.

Can Res Suppl. 1964 Dec:1093-353. No abstract available.

PMID:
5878218
12.

Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XV.

Leiter J, Abbott BJ, Bourke AR, Schepartz SA, Wodinsky I.

Cancer Res. 1963 Sep;23(8 Pt 2):1483-729. No abstract available.

13.

Antitumour activity of some cyclophosphazenes.

Labarre JF, Faucher JP, Levy G, Sournies F, Cros S, François G.

Eur J Cancer. 1979 May;15(5):637-43. No abstract available.

PMID:
510331
14.

Methanesulfonates: the relationship of structure to antitumor activity.

Sandberg JS, Wood HB Jr, Engle RR, Venditti JM, Goldin A.

Cancer Chemother Rep 2. 1972 Nov;3(1):137-229. No abstract available.

PMID:
4350012
15.

Chemotherapy studies on experimental mouse tumors. IX.

French FA, Blanz EJ Jr.

Cancer Chemother Rep 2. 1971 Apr;2(1):177-97. No abstract available.

PMID:
5565535
16.

[Antineoplastic activity of antibiotic 1719 from the group of diazo compounds].

Shorin VA, Averbukh LA, Bazhanov VS, Lepeshkina GN, Grinshteĭn AM.

Antibiotiki. 1972 Aug;17(8):675-80. Russian. No abstract available.

PMID:
4678532
17.

Kethoxal bis(thiosemicarbazone). I. Effects against experimental tumors.

Mihich E, Nichol CA.

Cancer Res. 1965 Oct;25(9):1410-6. No abstract available.

18.

Effect of AT1727 on growth and metastasis of murine tumours.

Li XT, Hutchinson GE, Pym BA, Finch M, Hellmann K.

Eur J Cancer Clin Oncol. 1983 Feb;19(2):283-7.

PMID:
6681774
19.

The antitumour activity of a series of benzothiophenes.

Hellmann K, Marshall PG, Stayt S.

Biochem Pharmacol. 1967 Apr;16(4):681-7. No abstract available.

PMID:
6033788
20.

Ifosfamide in experimental tumor systems.

Goldin A.

Semin Oncol. 1982 Dec;9(4 Suppl 1):14-23. Review. No abstract available.

PMID:
6761864

Supplemental Content

Support Center